ACE expression has been demonstrated to be elevated in the lungs of IPF patients (40–42), where it is thought to contribute to the development of fibrosis through effects of AngII on myofibroblasts and TGF-β signaling or through degradation of the antifibrotic peptide AcSDKP (43). This evidence concerns the gene AGT and idiopathic pulmonary fibrosis.